aspartic acid has been researched along with fluoxetine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aschner, M; Dave, V; Goderie, S; Kimelberg, HK; Mullaney, KJ | 1 |
| Lin, A; Maes, M; Scharpé, S; Vandoolaeghe, E; Verkerk, R | 1 |
| Chappell, RL; Schuette, E | 1 |
| De Keyser, J; Mostert, JP; Oudkerk, M; Sijens, PE | 1 |
| Blicharska, E; Brański, P; Cichy, A; Dybała, M; Nowak, G; Pilc, A; Piotrowska, A; Poleszak, E; Pomierny-Chamioło, L; Siwek, A; Szewczyk, B; Wlaź, P; Wróbel, A | 1 |
| Atli, A; Avcu, S; Besiroglu, L; Bora, A; Bulut, MD; Ozbebit, O; Selvi, Y; Sozen, M; Unal, O | 1 |
| Han, F; Shi, Y; Wen, L; Xiao, B | 1 |
| Dalla, C; Ferreira, C; Kokras, N; Melo, A; Pêgo, JM; Sousa, N; Ventura-Silva, AP | 1 |
| Januszko, P; Mach, A; Nowak, G; Pilc, A; Poleszak, E; Radziwoń-Zaleska, M; Ryszewska-Pokraśniewicz, B; Skalski, M; Wawrzyniak, ZM | 1 |
| Barkhof, F; Chataway, J; DeAngelis, F; Doshi, A; Gandini Wheeler-Kingshott, CAM; John, NA; MacManus, D; Marshall, I; Monteverdi, A; Parker, RA; Plantone, D; Prados, F; Schneider, T; Solanky, BS; Stutters, J; Weir, CJ | 1 |
4 trial(s) available for aspartic acid and fluoxetine
| Article | Year |
|---|---|
Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity.
Topics: Adult; Aged; Alanine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arginine; Asparagine; Aspartic Acid; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Excitatory Amino Acids; Female; Fluoxetine; Glycine; Histidine; Humans; Male; Middle Aged; Personality Inventory; Pindolol; Prognosis; Selective Serotonin Reuptake Inhibitors; Serine; Taurine; Threonine; Trazodone; Treatment Outcome | 1998 |
Fluoxetine increases cerebral white matter NAA/Cr ratio in patients with multiple sclerosis.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Aspartic Acid; Cerebral Cortex; Creatine; Female; Fluoxetine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis | 2006 |
Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response.
Topics: Adult; Affect; Aged; Antidepressive Agents, Second-Generation; Aspartic Acid; Depressive Disorder; Dietary Supplements; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Poland; Remission Induction; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Young Adult | 2018 |
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study.
Topics: Adult; Amiloride; Aspartic Acid; Biomarkers; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Fluoxetine; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Neuroimaging; Neuroprotective Agents; Proton Magnetic Resonance Spectroscopy; Protons; Riluzole | 2020 |
6 other study(ies) available for aspartic acid and fluoxetine
| Article | Year |
|---|---|
Astrocytes as mediators of methylmercury neurotoxicity: effects on D-aspartate and serotonin uptake.
Topics: Animals; Animals, Newborn; Aspartic Acid; Astrocytes; Autoradiography; Cells, Cultured; Fluoxetine; Immunohistochemistry; Methylmercury Compounds; Nervous System Diseases; Rats; Rats, Sprague-Dawley; Serotonin; Sodium | 1994 |
Excitatory amino acids and serotonin uptake blockers reveal two physiologically distinct serotonin systems in the retina of the skate, Raja erinacea.
Topics: Animals; Aspartic Acid; Excitatory Amino Acid Antagonists; Fluoxetine; Monoamine Oxidase Inhibitors; N-Methylaspartate; Organ Culture Techniques; Pargyline; Potassium; Retina; Selective Serotonin Reuptake Inhibitors; Serotonin; Skates, Fish; Zimeldine | 1998 |
The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Aspartic Acid; Citalopram; Fenclonine; Fluoxetine; Male; Mice; Morpholines; Motor Activity; Organometallic Compounds; Piperazines; Pyridines; Rats; Rats, Wistar; Reboxetine; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Antagonists; Swimming; Zinc Compounds | 2009 |
The involvement of distinct neural systems in patients with obsessive-compulsive disorder with autogenous and reactive obsessions.
Topics: Adult; Aspartic Acid; Choline; Creatine; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Female; Fluoxetine; Humans; Limbic System; Magnetic Resonance Spectroscopy; Male; Middle Aged; Obsessive Behavior; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2011 |
Effects of fluoxetine on the amygdala and the hippocampus after administration of a single prolonged stress to male Wistar rates: In vivo proton magnetic resonance spectroscopy findings.
Topics: Amygdala; Animals; Aspartic Acid; Choline; Creatine; Fluoxetine; Hippocampus; Male; Proton Magnetic Resonance Spectroscopy; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Stress, Psychological; Treatment Outcome | 2015 |
The positive effect on ketamine as a priming adjuvant in antidepressant treatment.
Topics: Animals; Antidepressive Agents; Anxiety; Aspartic Acid; Behavior, Animal; Brain; Depression; Depressive Disorder, Major; Disease Models, Animal; Drug Therapy, Combination; Fluoxetine; Glutamic Acid; Imipramine; Ketamine; Male; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Wistar; Stress, Psychological | 2015 |